Mobile Gaming is fastest growing segment fueling the growth of Infant Formula Market

 The global Infant Formula Market is estimated to be valued at US$ 38,983.06 Mn in 2023 and is expected to exhibit a CAGR of 10.6 % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Infant formula products aim to fulfill the nutritional needs of infants as a substitute for mother's milk. These products contain protein, vitamins, minerals, and other nutrients required for infant growth and development. Infant formula demand is increasing globally with rising number of working women and nuclear families.

Market key trends:
One of the key trends driving the growth of the infant formula market is the rising urbanization and increase in dual income households globally. With increasingly busy lifestyles, working women find it difficult to breastfeed and thus rely on infant formula as an alternative. This has resulted in the growing demand for formula suitable for newborns as well as toddlers. Manufacturers are launching innovative products with added prebiotics, probiotics or dairy-free/ organic options to cater to the evolving consumer preferences.

Segment Analysis
The infant formula market is dominated by standard infant formula segment due to wide availability and affordability. Standard infant formula closely mimics breast milk and is an ideal alternative to breast milk for infants who cannot be breastfed. It contains proteins, fats, carbohydrates, vitamins, and minerals that are essential for growth and development of infants. Rising number of working mothers who cannot breastfeed their babies has propelled the demand for standard infant formula products in the market.

Key Takeaways
The Global Infant Formula Market Size is expected to witness high growth, exhibiting CAGR of 10% over the forecast period, due to increasing number of working women population who are not able to breastfeed their babies.

Regional analysis:
Asia Pacific dominates the global infant formula market with over 40% share. China accounts for over half of Asia Pacific’s market share. High infant population along with rising disposable income levels in countries such as China and India make the region fastest growing. North America is another major market for infant formula driven by rising awareness about infant nutritional care.

Key players:
Key players operating in the infant formula market are Nestle S.A., Groupe Danone, Abbott Nutrition, Mead Johnson Nutrition, The Kraft Heinz Company, Meiji Holdings Co. Ltd., Beingmate Baby & Child food Co. Ltd., Synutra International Inc., Pfizer Inc., and FrieslandCampina. N.V. Nestle S.A. is the global market leader with strong portfolio of infant formula products including Nestle infant formula, Gerber, Good Start and others. Danone is another major player expanding its footprint through innovation.

 

Read more:  https://www.ukwebwire.com/infant-formula-market-size-forecast/

Comments

Post a Comment

Popular posts from this blog

Vegan Yogurt Market is Poised for Growth Driven by Rising Health Consciousness

Image
Vegan yogurt is a dairy-free alternative to conventional yogurt made from plant-based milk such as soy, almond, oat, coconut or rice. It provides similar texture and taste to dairy yogurt but without any animal products.Vegan yogurt offers several health advantages over dairy yogurt as it is devoid of lactose, cholesterol and saturated fats. The growing number of people adopting vegan and flexitarian diets has driven the demand for plant-based dairy alternatives like vegan yogurt. The global vegan yogurt market is estimated to be valued at US$ 4.15 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031. Key Takeaways Key players- Met Fods, Cocos Organic, Hain Celestial, EasiYo Product Limited, Danone, General Mills Inc., Stonyfield Far, Inc., Daiya Foods Inc.m Good Karma foods, Inc.m Hudson River Foodsm NANCY'S, Kite Hill, COYO Pty lTd., Nush Foods, Chobani, LLC, Barambah Oraganics Pty Ltd., Blue Diamond Growers, Dean Foodsm General Mills Inc
Read more

Hypoglycemic Drugs Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Diabetes in the Geriatric Population

Image
Hypoglycemic drugs or anti-diabetic drugs are medications used to treat diabetes mellitus by lowering blood glucose levels. Some key hypoglycemic drugs include insulin, sulfonylureas, metformin, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and GLP-1 receptor agonists. These drugs help control blood sugar levels in diabetics and prevent or delay diabetes-related health complications. The global hypoglycemic drugs market is estimated to be valued at US$ 720.72 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The growth of the global hypoglycemic drugs market is majorly driven by the increasing prevalence of diabetes in the geriatric population globally. As per estimates, around 1 in every 11 people aged 65 years and above have diabetes. Further, the number of people with diabetes in this age group is anticipated to grow from 25.9 million in 2017 to
Read more

Clinical Trials Rising with Digital Technologies Adoption

Image
 Clinical trials support services play a vital role in assisting sponsors and life science companies to conduct clinical trials in a precise and well-organized manner.These services assist pharmaceutical companies in patient recruitment, data management, site management, and overall clinical trial management. With rising complexities in clinical trials owing to integration of technologies like telehealth and remote patient monitoring, the demand for these support services is growing substantially. The global Clinical Trials Support Services Market is estimated to be valued at US$ 22.38 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The growing adoption of digital technologies across clinical trials is a key trend accelerating the growth of the clinical trials support services market. Digital tools like electronic data capture, clinical trial managemen
Read more